Chlorhexidine oral care

PreclinicalSmall molecule

TTanta University

Chlorhexidine oral care is one of 55 small molecule programs targeting Type 2 Diabetes. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Type 2 DiabetesActive, not recruiting

Ventilator-Associated PneumoniaActive, not recruiting

Type 2 DiabetesPreclinical

Active, not recruiting

Ventilator-Associated PneumoniaPreclinical

Active, not recruiting

Competition

Competitive Landscape

885 competitors in Type 2 Diabetes

#DrugCompanyPhaseTrials

NOVOLIN R

Novo Nordisk

Preclinical

5 2

Cysteine Hydrochloride

Novartis

Preclinical

1 3

Aurlumyn

BBTG International Inc.

Preclinical

1 4

Nexium

DDexcel Pharma Technologies Ltd.

Preclinical

1 5

Cecon

MMcGuff Pharmaceuticals, Inc.

Preclinical

1 6

Forxiga

AstraZeneca

Preclinical

3 7

Lovaza

AstraZeneca

Preclinical

1 8

Sulfonylureas

Eli Lilly

Preclinical

1 9

Acipimox

Boehringer Ingelheim

Preclinical

2 10

SGLT-2 Inhibitor

SSheffield Teaching Hospitals NHS Foundation Trust

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Type 2 Diabetes1 trial

Para-Probiotic Oral Care in Periodontal Patients With Type 2 Diabetes

Recruiting·UUniversity of Pavia·N/A·NCT07069166·40 enrolled

Ventilator-Associated Pneumonia1 trial

Oropharyngeal Care With Colostrum, Chlorohexidine and Sodium Bicarbonate in Preventing Ventilator-associated Pneumonia in Preterm Neonates

Active, not recruiting·TTanta University·N/A·NCT07482007·80 enrolled

Intensive Care1 trial

Ecological Effects of Decolonisation Strategies in Intensive Care

Completed·MMJM Bonten·Phase 3·NCT02208154·8,665 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Chlorhexidine oral care. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Chlorhexidine oral care compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Chlorhexidine oral care. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Tanta University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TTanta University

Chlorhexidine oral care

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Type 2 Diabetes1 trial

Ventilator-Associated Pneumonia1 trial

Intensive Care1 trial

References

Drug Info

Quick Facts

Related News